Skip to main content

Division of Gastroenterology Archives

Innovations improve the lives of patients with IBD

Jan. 9, 2024—Two recent innovations — point-of-care intestinal ultrasound and functional medicine — are improving the lives of patients at the Vanderbilt Inflammatory Bowel Disease Clinic at Vanderbilt Health One Hundred Oaks.

Read more


Vanderbilt mourns loss of former Gastroenterology director Burk

May. 3, 2023—Raymond Burk Jr., MD, former director of the Vanderbilt's Division of Gastroenterology, Hepatology and Nutrition, died May 1 in Nashville. He was 80.

Read more


Study finds that reducing intake of simple sugars improves GERD

Oct. 6, 2022—A Vanderbilt study found that reducing dietary carbohydrates improved both symptoms and objective measurements of gastroesophageal reflux disease (GERD) in a randomized controlled trial.

Read more


New prognosis predictor and target for gastric cancer

Apr. 7, 2022—The protein CGA — a subunit of glycoprotein hormones — is a biomarker that predicts chemoresistance in gastric cancer and could be targeted along with EGFR to restore chemosensitivity.

Read more


New Clinician Spotlight: Neil Price

Aug. 24, 2021—Neil Price, MD, assistant professor of Clinical Medicine, joined Vanderbilt University Medical Center recently and specializes in gastroenterology.

Read more


Potential biomarker for IBD severity, cancer risk identified

Feb. 4, 2021—A selenium transport protein produced in the colon may be a novel biomarker for assessing disease severity and cancer risk in patients with inflammatory bowel disease.

Read more


Possible COVID-19 “decoy”

Oct. 15, 2020—It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection.

Read more


A step toward gastric cancer

Oct. 3, 2019—New research findings provide insight into the detrimental events that develop in response to H. pylori infection.

Read more


Receptor’s role in stopping H. pylori

Apr. 25, 2019—The immune receptor NOD1 may be a prime target for preventing or treating H. pylori infections — the most significant risk factor for stomach cancer, Vanderbilt researchers have discovered.

Read more


Peek named to serve on NIDDK Advisory Council

Mar. 15, 2018—Richard Peek, MD, director of the Vanderbilt Digestive Disease Research Center (VDDRC) and chief of the Division of Gastroenterology, Hepatology and Nutrition, has been appointed to serve on the advisory council of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Read more


The toll of dysphagia

Dec. 15, 2017—Impaired swallowing — dysphagia — affects 3 percent of hospital inpatients, who have longer hospital stays and are more likely to require post-acute care services.

Read more


Peek named editor-in-chief of leading gastroenterology journal

May. 7, 2015—Richard Peek, M.D., director of the Vanderbilt Digestive Disease Research Center, has been appointed to a five-year term as editor-in-chief of the medical journal Gastroenterology beginning July 2016.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more